EarningsQ2 2024 Earnings Report

Outlook Therapeutics (41O) Q2 2024 Earnings Report

8 Followers

DE:41O Q2 2024 EPS Results

Actual EPS-€1.38

Consensus EPS-€0.81

Beat/MissMissed by -€0.57

One Year Ago EPS-€0.54

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2024

Date05/15/2024

TimeAfter Close

Conference CallWednesday, May 15, 2024

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

DE:41O Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.054	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.393	79.55% (+0.31)
May 15, 2026	2026 (Q2)	-0.11 / -0.14	-0.357	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.20	-0.794	75.28% (+0.60)
Dec 19, 2025	2025 (Q4)	-0.23 / -0.05	-0.785	93.18% (+0.73)
Aug 14, 2025	2025 (Q3)	-0.31 / -0.39	-0.741	46.99% (+0.35)
May 15, 2025	2025 (Q2)	-0.48 / -0.36	-1.383	74.19% (+1.03)
Feb 14, 2025	2025 (Q1)	-0.68 / -0.79	-0.714	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.72 / -0.79	-0.892	12.00% (+0.11)
Aug 14, 2024	2024 (Q3)	-0.92 / -0.74	-1.428	48.13% (+0.69)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed